Pricing and reimbursement
AIFA intervenes in the governance of pharmaceutical expenditure by negotiating the price of medicinal products and managing the National Pharmaceutical Formulary (PFN).
In addition, AIFA monitors the appropriateness of use of medicines through the development, management and analysis of registers and consumption data.
It periodically reviews the Notes, which are regulatory tools that define the eligibility for reimbursement of some medicinal products and are updated on the basis of new scientific evidence and the needs of daily medical practice on the national territory.
Every month, the Agency also publishes the updated transparency lists, which are the lists of medicinal products whose patent coverage has expired, with the relative reference prices.
08/06/2016
23/05/2016
23/02/2016
15/01/2016
14/01/2016
14/01/2016
24/12/2015
24/12/2015
23/12/2015
04/12/2015
27/11/2015
20/11/2015
18/11/2015
17/11/2015
16/11/2015
16/11/2015
16/11/2015
11/11/2015
05/11/2015
05/11/2015
04/11/2015
04/11/2015
04/11/2015
22/10/2015
20/10/2015
24/09/2015
16/09/2015